The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

As one of the world’s largest biopharma companies, Pfizer ($PFE) is no stranger to leveraging market dynamics to benefit the company and its ...

We recently published 11 Stocks Crushing Wall Street With Whopping Gains. GSK plc (NYSE:GSK) is one of the top performers on Tuesday. Shares of GSK rallied for a third straight day on Tuesday to hit a ...

Outgoing CEO Walmsley's bold R&D push ignites investor buzz as AstraZeneca and GSK shares jump on deal optimism ...

GSK chief executive Emma Walmsley is to step down after more than eight years running the pharmaceuticals giant.

Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

GSK plc (LSE/NYSE: GSK) today announced a major update to Vaccine Track, a first-of-its-kind, interactive public data tool for tracking adult immunization activity in the US. Users can now explore ...

McCarter & English launched a wave of patent infringement lawsuits on behalf of biotech giants in Delaware federal court this month—three of which are pursuing injunctions against companies for ...

The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of clarity after a volatile year during which Trump has taken aim at the ...

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower prescription drug prices led to an accord with Pfizer in exchange for tariff ...